Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) EBT Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported EBT Margin over the past 16 years, most recently at 3.06% for Q2 2025.

  • For Q2 2025, EBT Margin rose 1580.0% year-over-year to 3.06%; the TTM value through May 2025 reached 30.01%, down 3743.0%, while the annual FY2025 figure was 30.01%, 3743.0% down from the prior year.
  • EBT Margin for Q2 2025 was 3.06% at Lifecore Biomedical, Inc. \De\, up from 42.04% in the prior quarter.
  • Over five years, EBT Margin peaked at 47.02% in Q4 2023 and troughed at 118.05% in Q2 2023.
  • A 5-year average of 29.73% and a median of 35.14% in 2025 define the central range for EBT Margin.
  • Biggest five-year swings in EBT Margin: skyrocketed 9920bps in 2024 and later crashed -8405bps in 2025.
  • Year by year, EBT Margin stood at 4.97% in 2021, then plummeted by -947bps to 42.06% in 2022, then soared by 212bps to 47.02% in 2023, then crashed by -143bps to 20.05% in 2024, then surged by 85bps to 3.06% in 2025.
  • Business Quant data shows EBT Margin for LFCR at 3.06% in Q2 2025, 42.04% in Q1 2025, and 20.05% in Q4 2024.